Basic and diluted loss per share for 2024 amounted to €0.40 compared to €0.65 in 2023. The average number of shares outstanding in 2024 increased versus 2023, as a result of the capital increase in ...
Briefly on MSN3h
Gent shares new location foreigners should visit in Cape TownA South African man from Cape Town proposed a change of scenery for tourists visiting the mother city. He urged them to visit ...
On 3 April 2024, the Company announced publication of the results of the RED DESERT and SAHARA proof-of-concept studies, in the prestigious peer-reviewed journal European Journal of Heart Failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback